🏛️ Verified NIH Record • Updated 2024-08-19
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure (NCT04149743)
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]
🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Aventusoft, LLC.
🩺 Plain-English Summary (8th-Grade Level)
Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.
Who can join: Review the eligibility criteria below.
Location: Cleveland Clinic Florida — Weston, Florida
Age range: 22 Years
🧪 Interventions in This Study
- Standard of Care with Hemotag (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Cleveland Clinic Florida — Weston, Florida
- Baylor Scott & White Research Institute — Temple, Texas
📞 Contact the Study Coordinator
Phone: (561) 945-9303
Email: cindy@aventusoft.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure (HF)
Explore by condition: All Heart Failure (HF) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.